• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国糖尿病患者接受终末期肾病治疗的比例持续下降。

Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline.

机构信息

Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

出版信息

Diabetes Care. 2010 Jan;33(1):73-7. doi: 10.2337/dc09-0343.

DOI:10.2337/dc09-0343
PMID:20040673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2797989/
Abstract

OBJECTIVE

We examined trends in incidence of treatment for diabetes-related end-stage renal disease (ESRD) in the U.S.

RESEARCH DESIGN AND METHODS

Using the U.S. Renal Data System, we obtained the number of individuals having diabetes listed as primary diagnosis who initiated ESRD treatment between 1990 and 2006. Incidence was calculated using the estimated U.S. population with diabetes from the National Health Interview Survey and then was age adjusted based on the 2000 U.S. standard population. Trends were analyzed using joinpoint regression.

RESULTS

The number of individuals who began diabetes-related ESRD treatment increased from 17,727 in 1990 to 48,215 in 2006. From 1990 to 1996, the age-adjusted diabetes-related ESRD incidence increased somewhat from 299.0 to 343.2 per 100,000 diabetic population (P = 0.45). However, from 1996 to 2006, the age-adjusted diabetes-related ESRD incidence decreased by 3.9% per year (P < 0.01) from 343.2 to 197.7 per 100,000 diabetic population. Among individuals with diabetes aged <45 years, diabetes-related ESRD incidence decreased by 4.3% per year (P < 0.01) from 1990 to 2006. Among older individuals, incidence increased during the 1990s but decreased in later years, by 3.9% per year (P < 0.01) among individuals aged 45-64, by 3.4% per year (P < 0.01) among individuals aged 65-74 years, and by 2.1% per year (P = 0.02) among individuals aged > or =75 years.

CONCLUSIONS

Diabetes-related ESRD incidence in the diabetic population has declined in all age-groups, probably because of a reduction in the prevalence of ESRD risk factors, improved treatment and care, and other factors.

摘要

目的

我们在美国研究了与糖尿病相关的终末期肾病(ESRD)治疗发病率的趋势。

研究设计与方法

利用美国肾脏数据系统,我们获得了 1990 年至 2006 年间患有糖尿病并开始 ESRD 治疗的患者人数。发病率根据国家健康访谈调查估计的美国糖尿病患者数量进行计算,然后根据 2000 年美国标准人口进行年龄调整。趋势分析采用联合点回归法。

结果

开始进行与糖尿病相关的 ESRD 治疗的患者人数从 1990 年的 17727 人增加到 2006 年的 48215 人。1990 年至 1996 年,经年龄调整的与糖尿病相关的 ESRD 发病率从 299.0 略微增加到 343.2/每 10 万糖尿病患者(P = 0.45)。然而,从 1996 年到 2006 年,经年龄调整的与糖尿病相关的 ESRD 发病率每年下降 3.9%(P < 0.01),从 343.2/每 10 万糖尿病患者降至 197.7/每 10 万糖尿病患者。在年龄<45 岁的糖尿病患者中,1990 年至 2006 年,与糖尿病相关的 ESRD 发病率每年下降 4.3%(P < 0.01)。在年龄较大的患者中,发病率在 1990 年代上升,但在随后几年下降,45-64 岁的患者每年下降 3.9%(P < 0.01),65-74 岁的患者每年下降 3.4%(P < 0.01),年龄>或=75 岁的患者每年下降 2.1%(P = 0.02)。

结论

所有年龄段的糖尿病患者中,与糖尿病相关的 ESRD 发病率都有所下降,这可能是由于 ESRD 危险因素的流行率降低、治疗和护理的改善以及其他因素所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95d/2797989/084823fed164/zdc0011079630002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95d/2797989/8d7f92449578/zdc0011079630001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95d/2797989/084823fed164/zdc0011079630002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95d/2797989/8d7f92449578/zdc0011079630001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95d/2797989/084823fed164/zdc0011079630002.jpg

相似文献

1
Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline.美国糖尿病患者接受终末期肾病治疗的比例持续下降。
Diabetes Care. 2010 Jan;33(1):73-7. doi: 10.2337/dc09-0343.
2
Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes - United States and Puerto Rico, 2000-2014.2000 - 2014年美国及波多黎各确诊糖尿病患者中糖尿病所致终末期肾病的发病率
MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1165-1170. doi: 10.15585/mmwr.mm6643a2.
3
Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes --- United States and Puerto Rico, 1996-2007.1996-2007 年美国和波多黎各被诊断患有糖尿病的患者中归因于糖尿病的终末期肾病的发病率。
MMWR Morb Mortal Wkly Rep. 2010 Oct 29;59(42):1361-6.
4
Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk.加那利群岛糖尿病相关终末期肾病发病率极高。基于估计的危险人群分析。
Nephrol Dial Transplant. 2010 Jul;25(7):2283-8. doi: 10.1093/ndt/gfp761. Epub 2010 Jan 11.
5
Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.1998 - 2002年欧洲、加拿大及亚太地区20 - 64岁人群中接受治疗的终末期肾病发病率趋势,总体及按原发性肾病分类的发病率趋势
Nephrology (Carlton). 2007 Oct;12(5):520-7. doi: 10.1111/j.1440-1797.2007.00830.x.
6
Trends in incidence of end-stage renal disease among persons with diagnosed diabetes--Puerto Rico, 1996-2010.1996-2010 年波多黎各诊断为糖尿病的人群中终末期肾病发病率的变化趋势。
MMWR Morb Mortal Wkly Rep. 2014 Mar 7;63(9):186-9.
7
End-stage renal disease due to diabetes among southwestern American Indians, 1990-2001.1990 - 2001年美国西南部印第安人中由糖尿病导致的终末期肾病
Diabetes Care. 2005 May;28(5):1041-4. doi: 10.2337/diacare.28.5.1041.
8
Trends of Nontraumatic Lower-Extremity Amputation in End-Stage Renal Disease and Diabetes: United States, 2000-2015.终末期肾病和糖尿病患者非创伤性下肢截肢的趋势:美国,2000-2015 年。
Diabetes Care. 2019 Aug;42(8):1430-1435. doi: 10.2337/dc19-0296. Epub 2019 May 29.
9
Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.青少年起病的2型糖尿病对年轻及中年皮马印第安人终末期肾病发病率和死亡率的影响。
JAMA. 2006 Jul 26;296(4):421-6. doi: 10.1001/jama.296.4.421.
10
The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease.糖尿病患病率增加以及心肌梗死和中风生存率提高对接受治疗的终末期肾病增加的影响。
J Am Soc Nephrol. 2003 Jun;14(6):1568-77. doi: 10.1097/01.asn.0000067420.83632.c1.

引用本文的文献

1
Hallmarks of Quercetin Benefits as a Functional Supplementary in the Management of Diabetes Mellitus-Related Maladies: From Basic to Clinical Applications.槲皮素作为功能性补充剂在糖尿病相关疾病管理中的益处:从基础到临床应用的特点。
Curr Drug Metab. 2024;25(9):653-669. doi: 10.2174/0113892002339410250108031621.
2
The advance of single cell transcriptome to study kidney immune cells in diabetic kidney disease.单细胞转录组学在研究糖尿病肾病中肾脏免疫细胞的进展。
BMC Nephrol. 2024 Nov 16;25(1):412. doi: 10.1186/s12882-024-03853-y.
3
The problem of pulmonary arterial hypertension in end-stage renal disease: can peritoneal dialysis be the solution.

本文引用的文献

1
Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.1999年至2006年美国糖尿病患病率及治疗目标达成情况
Am J Med. 2009 May;122(5):443-53. doi: 10.1016/j.amjmed.2008.09.047.
2
Patient awareness of chronic kidney disease: trends and predictors.慢性肾脏病患者的知晓情况:趋势与预测因素
Arch Intern Med. 2008 Nov 10;168(20):2268-75. doi: 10.1001/archinte.168.20.2268.
3
Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004.
终末期肾病肺动脉高压问题:腹膜透析能否成为解决方案。
BMC Nephrol. 2022 Dec 5;23(1):386. doi: 10.1186/s12882-022-02998-y.
4
Galectin-1 in Obesity and Type 2 Diabetes.肥胖与2型糖尿病中的半乳糖凝集素-1
Metabolites. 2022 Sep 30;12(10):930. doi: 10.3390/metabo12100930.
5
Sarcopenia Is an Independent Risk Factor for Severe Diabetic Nephropathy in Type 2 Diabetes: A Long-Term Follow-Up Propensity Score-Matched Diabetes Cohort Study.肌肉减少症是2型糖尿病患者发生严重糖尿病肾病的独立危险因素:一项长期随访倾向评分匹配的糖尿病队列研究。
J Clin Med. 2022 May 25;11(11):2992. doi: 10.3390/jcm11112992.
6
Obesity and Chronic Kidney Disease in US Adults With Type 1 and Type 2 Diabetes Mellitus.美国 1 型和 2 型糖尿病成人的肥胖与慢性肾脏病。
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1247-1256. doi: 10.1210/clinem/dgab927.
7
Epidemiological characteristics of diabetic kidney disease in Taiwan.台湾地区糖尿病肾病的流行病学特征。
J Diabetes Investig. 2021 Dec;12(12):2112-2123. doi: 10.1111/jdi.13668. Epub 2021 Oct 3.
8
Single Cell Transcriptome Helps Better Understanding Crosstalk in Diabetic Kidney Disease.单细胞转录组有助于更好地理解糖尿病肾病中的细胞间相互作用。
Front Med (Lausanne). 2021 Aug 17;8:657614. doi: 10.3389/fmed.2021.657614. eCollection 2021.
9
Trends in kidney failure and kidney replacement therapy in people with diabetes in Hong Kong, 2002-2015: A retrospective cohort study.2002 - 2015年香港糖尿病患者肾衰竭及肾脏替代治疗趋势:一项回顾性队列研究
Lancet Reg Health West Pac. 2021 Jun 9;11:100165. doi: 10.1016/j.lanwpc.2021.100165. eCollection 2021 Jun.
10
Renal Replacement Therapy in People With and Without Diabetes in Germany, 2010-2016: An Analysis of More Than 25 Million Inhabitants.德国 2010-2016 年有和无糖尿病患者的肾脏替代治疗:对超过 2500 万居民的分析。
Diabetes Care. 2021 Jun;44(6):1291-1299. doi: 10.2337/dc20-2477. Epub 2021 May 4.
1999 - 2004年美国国家健康与营养检查调查中已诊断糖尿病的患病率、治疗及控制情况
Ann Epidemiol. 2008 Mar;18(3):222-9. doi: 10.1016/j.annepidem.2007.10.007. Epub 2008 Jan 16.
4
Prevalence of chronic kidney disease in the United States.美国慢性肾脏病的患病率。
JAMA. 2007 Nov 7;298(17):2038-47. doi: 10.1001/jama.298.17.2038.
5
Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002.糖尿病护理流程及中间结果的改善:美国,1988 - 2002年
Ann Intern Med. 2006 Apr 4;144(7):465-74. doi: 10.7326/0003-4819-144-7-200604040-00005.
6
Incidence of end-stage renal disease among persons with diabetes--United States, 1990-2002.1990 - 2002年美国糖尿病患者中终末期肾病的发病率
MMWR Morb Mortal Wkly Rep. 2005 Nov 4;54(43):1097-100.
7
Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000.1971 - 2000年美国糖尿病成年患者心血管危险因素水平的30年趋势:国家健康与营养检查调查
Am J Epidemiol. 2004 Sep 15;160(6):531-9. doi: 10.1093/aje/kwh232.
8
Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.美国慢性肾功能不全进展至终末期肾病的种族差异。
J Am Soc Nephrol. 2003 Nov;14(11):2902-7. doi: 10.1097/01.asn.0000091586.46532.b4.
9
Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy.1型和2型糖尿病中的微量白蛋白尿:血管紧张素转换酶抑制剂和血管紧张素II受体阻滞剂治疗早期及预防临床肾病的证据
Curr Hypertens Rep. 2002 Oct;4(5):387-93. doi: 10.1007/s11906-002-0069-3.
10
Permutation tests for joinpoint regression with applications to cancer rates.用于连接点回归的排列检验及其在癌症发病率中的应用。
Stat Med. 2000 Feb 15;19(3):335-51. doi: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z.